首页> 外文期刊>Journal of Fish Diseases >Investigation of media formulations promoting differential antigen expression by Photobacterium damsela ssp piscicida and recognition by sea bass, Dicentrarchus labrax (L.), immune sera
【24h】

Investigation of media formulations promoting differential antigen expression by Photobacterium damsela ssp piscicida and recognition by sea bass, Dicentrarchus labrax (L.), immune sera

机译:培养基配方研究,该配方可促进达姆瑟氏菌属细菌的差异抗原表达以及海鲈,鲈鱼,免疫血清的识别

获取原文
获取原文并翻译 | 示例
           

摘要

Photobacterium damsela ssp. piscicida (Phdp ) isolates were grown in various bacteriological media, in eukaryotic cell culture media and in the presence of fish cells (resembling some aspects of in vivo growth environments). Bacterial cells, extracellular products (ECPs) and crude capsular polysaccharide were isolated and analysed by electrophoresis and Western blot using sea bass sera. Growth in bacteriological media conserved the synthesis of cell and extracellular components when these were compared with those prepared under near-in vivo growth conditions. In fact, synthesis of a larger range of cell components was induced after growth in bacteriological media. Certain media based on yeast extract and peptones from various sources and a specific salt formulation induced the synthesis of novel cell components at approximately 21.3 and 14 kDa. These antigens were recognized by sea bass sera collected after natural pasteurellosis outbreaks and other sea bass sera raised against live or inactivated Phdp cells. The ECPs of the pathogen were not good immunogens in their soluble form despite various treatments prior to immunization. The results are discussed with respect to vaccine development.
机译:发光细菌damsela ssp。在各种细菌学培养基,真核细胞培养基中以及在有鱼细胞存在的情况下(类似于体内生长环境的某些方面),都生长出了幽门螺杆菌(Phdp)分离株。分离细菌细胞,细胞外产物(ECP)和粗荚膜多糖,并使用鲈鱼血清通过电泳和Western印迹进行分析。当将它们与在接近体内生长条件下制备的细胞和细胞外成分进行比较时,细菌培养基中的生长可以保护细胞和细胞外成分的合成。实际上,在细菌培养基中生长后,诱导了更大范围的细胞成分的合成。基于酵母提取物和来自各种来源的蛋白ept的特定培养基以及特定的盐配方,诱导了大约21.3和14 kDa的新细胞成分的合成。这些抗原被自然巴氏杆菌病爆发后收集的鲈鱼血清和针对活的或灭活的Phdp细胞培养的其他鲈鱼血清识别。尽管在免疫之前进行了各种处理,但病原体的ECP并不是可溶性形式的良好免疫原。讨论了有关疫苗开发的结果。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号